These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1152599)

  • 41. Effects of structural modifications of N-CPM-normorphine derivatives on agonist and antagonist activities in isolated organs.
    Riba P; Tóth Z; Hosztafi S; Friedmann T; Fürst S
    Acta Biol Hung; 2003; 54(2):177-81. PubMed ID: 14535623
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interactions between morphine and the opioid-like peptides in the rat vas deferens.
    Huidobro F; Huidobro-Toro JP; Miranda H
    Br J Pharmacol; 1980 Dec; 70(4):519-25. PubMed ID: 6258678
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effect of chronic morphine treatment of excitatory junction potentials in the mouse vas deferens.
    North RA; Vitek LV
    Br J Pharmacol; 1980 Mar; 68(3):399-405. PubMed ID: 7052335
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vivo and in vitro investigation of naltrindole, a delta-opioid antagonist.
    Ayres EA; Davis P; Burks TF
    Proc West Pharmacol Soc; 1990; 33():55-63. PubMed ID: 2177196
    [No Abstract]   [Full Text] [Related]  

  • 45. Genotype dependent responses to ethanol and normorphine on vas deferens of inbred strains of mice.
    Blum K; Briggs AH; DeLallo L; Elston SF
    Subst Alcohol Actions Misuse; 1980; 1(5-6):459-65. PubMed ID: 7302794
    [No Abstract]   [Full Text] [Related]  

  • 46. Evidence for morphine and morphine-like alkaloid responses resistant to naloxone blockade in the rat vas deferens.
    Miranda H; Huidobro F; Huidobro-Toro JP
    Life Sci; 1979 Apr; 24(16):1511-18. PubMed ID: 224278
    [No Abstract]   [Full Text] [Related]  

  • 47. Synthesis and opioid activities of stereoisomers and other D-amino acid analogs of methionine-enkephalin.
    Coy DH; Kastin AJ; Schally AV; Morin O; Caron NG; Labrie F; Walker JM; Fertel R; Berntson GG; Sandman CA
    Biochem Biophys Res Commun; 1976 Dec; 73(3):632-8. PubMed ID: 1008880
    [No Abstract]   [Full Text] [Related]  

  • 48. Depression by morphine of excitatory junction potentials in the vas deferens of the mouse.
    Henderson G; North RA
    Br J Pharmacol; 1976 Jul; 57(3):341-6. PubMed ID: 974315
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Discrimination by temperature of opiate agonist and antagonist receptor binding.
    Creese I; Pasternak GW; Pert CB; Snyder SH
    Life Sci; 1975 Jun; 16(12):1837-42. PubMed ID: 1152613
    [No Abstract]   [Full Text] [Related]  

  • 50. [Isolation and amino acid composition of casein peptides stimulating growth if Streptococcus thermophilus].
    Desmazeaud MJ; Hermier JH
    Eur J Biochem; 1972 Jul; 28(2):190-8. PubMed ID: 4677725
    [No Abstract]   [Full Text] [Related]  

  • 51. Inhibition of neuroeffector transmission by morphine in the vas deferens of naive and morphine-treated mice.
    Illes P; Schulz R
    Br J Pharmacol; 1980; 71(1):195-200. PubMed ID: 6258687
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of morphine on adrenergic transmission in the mouse vas deferens. Assessment of agonist and antogonist potencies of narcotic analgesics.
    Hughes J; Kosterlitz HW; Leslie FM
    Br J Pharmacol; 1975 Mar; 53(3):371-81. PubMed ID: 236796
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clocinnamox dose-dependently antagonizes morphine-analgesia and [3H]DAMGO binding in rats.
    Paronis CA; Woods JH
    Eur J Pharmacol; 1997 Oct; 337(1):27-34. PubMed ID: 9389377
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Calcium reverses the inhibitory action of morphine on neuroeffector transmission in the mouse vas deferens.
    Illes P; Zieglgänsberger W; Herz A
    Brain Res; 1980 Jun; 191(2):511-22. PubMed ID: 6247017
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Extraordinary potency of a novel delta opioid receptor agonist is due in part to increased efficacy.
    Kramer TH; Bartosz-Bechowski H; Davis P; Hruby VJ; Porreca F
    Life Sci; 1997; 61(2):129-35. PubMed ID: 9217271
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Functional opiate receptor in mouse vas deferens: evidence for a complex interaction.
    Sánchez-Blázquez P; Garzón J; Lee NM
    J Pharmacol Exp Ther; 1983 Sep; 226(3):706-11. PubMed ID: 6310079
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Purification of a reticuloendothelial system-depressing substance produced in shock.
    Blattberg B; Frosolono MF; Misra RP; Levy MN
    J Reticuloendothel Soc; 1972 Oct; 12(4):371-86. PubMed ID: 4634517
    [No Abstract]   [Full Text] [Related]  

  • 58. Alpha-and beta-halomorphides: stereochemistry, analgesic potency, toxicity, and interaction with narcotic receptors in vitro.
    Yeh HJ; Wilson RS; Klee WA; Jacobson AE
    J Pharm Sci; 1976 Jun; 65(6):902-4. PubMed ID: 932978
    [TBL] [Abstract][Full Text] [Related]  

  • 59. DAMGO and 6beta-glycine substituted 14-O-methyloxymorphone but not morphine show peripheral, preemptive antinociception after systemic administration in a mouse visceral pain model and high intrinsic efficacy in the isolated rat vas deferens.
    Al-Khrasani M; Spetea M; Friedmann T; Riba P; Király K; Schmidhammer H; Furst S
    Brain Res Bull; 2007 Oct; 74(5):369-75. PubMed ID: 17845912
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Morphine dependence and diabetes. II. Alterations of normorphine potency in the guinea-pig ileum and mouse vas deferens and of ileal morphine dependence by changes in glucose concentration.
    Shook JE; Kachur JF; Brase DA; Dewey WL
    J Pharmacol Exp Ther; 1986 Jun; 237(3):848-52. PubMed ID: 3712282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.